AD |
Alzheimer’s disease |
ACE2 |
Angiotensin-converting enzyme 2 |
Apoe4 |
Apolipoprotein E4 |
BBB |
Blood–brain barrier |
CNS |
Central nervous system |
CSF |
Cerebrospinal fluid |
CXCL8 |
Chemokine (C-X-C motif) ligand 8 |
COVID-19 |
Coronavirus disease-2019 |
CRH |
Corticotropin-releasing hormone |
DAMPs |
Damage-associated molecular patterns (DAMPs) |
GFAP |
Glial fibrillary acidic protein |
HK-1 |
Hemokinin-1 |
HLA |
Human leukocyte antigen |
Iba1 |
Calcium-binding adapter molecule 1 |
IL-1β |
Interleukin-1 beta |
LPS |
Lipopolysaccharide |
MMCP6, 7 |
Mast cell proteases 6 and 7 |
MAP-2 |
Microtubule-associated protein-2 |
MCI |
Mild cognitive impairment |
mtDNA |
Mitochondrial DNA |
MS |
Multiple sclerosis |
NGF |
Nerve growth factor |
NfL |
Neurofilament light chain |
NK-1 |
Neurokinin-1 |
NLGs |
Neuroligins |
NT |
Neurotensin |
NSAIDs |
Non-steroidal anti-inflammatory drugs |
NF-κB |
Nuclear factor kappa B |
NLRP3 |
Nucleotide-binding domain (NOD)-like receptor protein 3 |
PAMPs |
Pathogen-associated molecular patterns |
PD |
Parkinson’s disease |
PASC |
Post-acute sequelae of SARS-CoV-2 |
PTSD |
Post-traumatic stress disorder |
S |
Spike |
SARS-CoV-3 |
Severe Acute respiratory syndrome coronavirus 2 |
SP |
Substance P |
TLRs |
Toll-like receptors |
TNF |
Tumor necrosis factor |